Expand ARQT Menu
ARQT MENU

Arcutis Biotherapeutics (ARQT) closed at $27.33 on November 17, 2026, up 0.7% from the previous close, on volume of 1,246,364 shares (30-day average 2,332,341).

Key numbers
  • Last close: $27.33 (November 17, 2026)
  • 52-week range: $19.30 to $34.80
  • Market value: $3.4 billion
  • 30-day implied volatility (IV30): 31.9%
  • Option volume: 9 contracts (9 calls, 0 puts); 30-day average 373

Data as of November 17, 2026.

ARQT Stock Summary and Trading Ideas (Arcutis Biotherapeutics | NASDAQ:ARQT)

Charts for Today's Stock Price and Implied Volatility in Arcutis Biotherapeutics

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for ARQT by Theoretical Edge and Win Rates

Sentiment

Largest Multi-Leg Option Trades (30 Days)

#DateStrategyLegsContracts

Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 17, 2026. See the largest for 5, 30, 60 and 90 days

News

Trading Statistics

Key Ratios

Arcutis Biotherapeutics (ARQT) Frequently Asked Questions

What does Arcutis Biotherapeutics do?

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

What symbol and exchange does Arcutis Biotherapeutics shares trade?

Arcutis Biotherapeutics trades on the NASDAQ stock market under the symbol ARQT.

What is Arcutis Biotherapeutics stock price doing today?

As of November 18, 2026, ARQT stock price climbed to $27.70 with 271,667 million shares trading.

What is Arcutis Biotherapeutics's Beta?

ARQT has a beta of 0.87, meaning it tends to be less sensitive to market movements. ARQT has a correlation of 0.05 to the broad based SPY ETF.

How much is Arcutis Biotherapeutics worth?

ARQT has a market cap of $3.48 billion. This is considered a Mid Cap stock.

How much money does Arcutis Biotherapeutics make?

Last quarter Arcutis Biotherapeutics reported $144 million in Revenue and $.06 earnings per share. This beat revenue expectation by $2 million and missed earnings estimates by -$.11.

What is the highest and lowest price Arcutis Biotherapeutics traded in the last 3 year period?

In the last 3 years, ARQT traded as high as $34.80 and as low as $1.76.

What are the top ETFs holding Arcutis Biotherapeutics?

The top ETF exchange traded funds that ARQT belongs to (by Net Assets): IJR, VTI, XBI, IWM, VXF.

Is Arcutis Biotherapeutics (ARQT) a good investment?

ARQT has underperformed the market in the last year with a price return of +5.8% while the SPY ETF gained +11.2%. However, in the short term, ARQT had mixed performance relative to the market. It has outperformed in the last 3 months, returning +8.2% vs -4.9% return in SPY. But in the last 2 weeks, ARQT shares have been beat by the market, returning -13.4% compared to an SPY return of -2.8%.

What are the support and resistance levels for Arcutis Biotherapeutics (ARQT)?

ARQT support price is $26.49 and resistance is $28.17 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ARQT shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes